Literature DB >> 20949888

Common types of supraventricular tachycardia: diagnosis and management.

Randall A Colucci1, Mitchell J Silver, Jay Shubrook.   

Abstract

The most common types of supraventricular tachycardia are caused by a reentry phenomenon producing accelerated heart rates. Symptoms may include palpitations (pulsation in the neck), chest pain, lightheadedness or dizziness, and dyspnea. It is unusual for supraventricular tachycardia to be caused by structurally abnormal hearts. Diagnosis is often delayed because of the misdiagnosis of anxiety or panic disorder. Patient history is important in uncovering the diagnosis, whereas the physical examination may or may not be helpful, and usually necessitates use of a Holter monitor or an event recorder to capture the arrhythmia and confirm a diagnosis. Treatment consists of short-term or as needed pharmacotherapy using calcium channel or beta blockers when vagal maneuvers fail to halt or slow the rhythm. In those who require long-term pharmacotherapy, atrioventricular nodal blocking agents or class IC or III antiarrhythmics can be used; however, these agents should generally be managed by a cardiologist. Catheter ablation is an option in patients with persistent or recurrent supraventricular tachycardia who are unable to tolerate long-term pharmacologic management. If Wolff-Parkinson-White syndrome is present, expedient referral to a cardiologist is warranted because ablation is a potentially curative option.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20949888

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  8 in total

1.  Clinical presentation of paroxysmal supraventricular tachycardia: evaluation of usual and unusual symptoms.

Authors:  Ertan Yetkin; Selcuk Ozturk; Bilal Cuglan; Hasan Turhan
Journal:  Cardiovasc Endocrinol Metab       Date:  2020-05-15

Review 2.  Esmolol: a review of its use in the short-term treatment of tachyarrhythmias and the short-term control of tachycardia and hypertension.

Authors:  Karly P Garnock-Jones
Journal:  Drugs       Date:  2012-01-01       Impact factor: 11.431

3.  Cardiac sarcoidosis resembling panic disorder: a case report.

Authors:  Keita Tokumitsu; Jun Demachi; Yukichi Yamanoi; Shigeto Oyama; Junko Takeuchi; Koji Yachimori; Norio Yasui-Furukori
Journal:  BMC Psychiatry       Date:  2017-01-13       Impact factor: 3.630

4.  Hemochromatosis as Junctional Tachycardia, a Rare Presentation.

Authors:  Ali Ghani; Irfan Ahsan; Charles Gottleib
Journal:  Clin Pract       Date:  2017-08-03

5.  Asthma-like attacks terminated by slow pathway ablation.

Authors:  Selcuk Ozturk; Hasan Turhan; Ertan Yetkin
Journal:  Ann Thorac Med       Date:  2017 Apr-Jun       Impact factor: 2.219

6.  From darkness, a light shall spring: Zero-fluoroscopic ablation of supraventricular tachycardia in a pregnant lady.

Authors:  Mohd Ridzuan Mohd Said; Sathvinder Singh Gian Singh; Kuo Ting Lee; Leet Ming Khor; Chin Yung Chea; Anand Raj Silveraju; Mohd Al-Baqlish Mohd Firdaus; Dharmaraj Karthikesan; Annamalar Muthu Muthuppalaniappan; Abdul Syukur Abdullah; Omar Ismail; Kantha Rao Narasamuloo; Saravanan Krishinan
Journal:  J Arrhythm       Date:  2020-12-26

7.  Prehospital conversion of paroxysmal supraventricular tachycardia using the modified Valsalva maneuver: A case report.

Authors:  Padarath Gangaram; Yugan Pillay; Bernard Christopher Pillay; Guillaume Alinier
Journal:  Qatar Med J       Date:  2020-11-27

Review 8.  In The Line of Treatment: A Systematic Review of Paroxysmal Supraventricular Tachycardia.

Authors:  Farrukh Ahmad; Majdi Abu Sneineh; Ravi S Patel; Sai Rohit Reddy; Adiona Llukmani; Ayat Hashim; Dana R Haddad; Domonick K Gordon
Journal:  Cureus       Date:  2021-06-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.